{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:59:25Z","timestamp":1791284365954,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1682,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P01 CA30206 and P50 CA107399"],"award-info":[{"award-number":["P01 CA30206 and P50 CA107399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"General Clinical Research Center","award":["M01 RR0004"],"award-info":[{"award-number":["M01 RR0004"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bbmt.2010.03.014","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T06:44:51Z","timestamp":1269326691000},"page":"1245-1256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":445,"title":["Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20\/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans"],"prefix":"10.1016","volume":"16","author":[{"given":"Michael C.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Popplewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence J.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"DiGiusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Ostberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.03.014_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2174\/138945006778559120","article-title":"Current status of immunotherapy in B cell malignancies","volume":"7","author":"Kofler","year":"2006","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bbmt.2010.03.014_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.med.59.060906.220345","article-title":"A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma","volume":"59","author":"Molina","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bbmt.2010.03.014_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10238-009-0037-1","article-title":"Immunomodulation in the treatment of haematological malignancies","volume":"9","author":"Cesco-Gaspere","year":"2009","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.bbmt.2010.03.014_bib4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02986612","article-title":"Immunotherapy for lymphomas","volume":"77","author":"Timmerman","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2009.02.009","article-title":"The promise and potential pitfalls of chimeric antigen receptors","volume":"21","author":"Sadelain","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/asheducation-2007.1.250","article-title":"Engineering antitumor immunity by T-cell adoptive immunotherapy","author":"Riddell","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2010.03.014_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/bbmt.1998.v4.pm9763110","article-title":"CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy","volume":"4","author":"Jensen","year":"1998","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.014_bib8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2002-07-1989","article-title":"T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect","volume":"101","author":"Cooper","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.03.014_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/mthe.1999.0012","article-title":"Human T lymphocyte genetic modification with naked DNA","volume":"1","author":"Jensen","year":"2000","journal-title":"J Mol Ther"},{"key":"10.1016\/j.bbmt.2010.03.014_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jgm.489","article-title":"Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma","volume":"6","author":"Gonzalez","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.bbmt.2010.03.014_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/14653240600620176","article-title":"Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma","volume":"8","author":"Cooper","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2010.03.014_bib12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.mt.6300104","article-title":"Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma","volume":"15","author":"Park","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.bbmt.2010.03.014_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1399-0039.1999.530202.x","article-title":"Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition","volume":"53","author":"Akatsuka","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2010.03.014_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"issue":"Suppl 12","key":"10.1016\/j.bbmt.2010.03.014_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.22719","article-title":"The non-Hodgkin lymphomas: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bbmt.2010.03.014_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.soncn.2006.01.002","article-title":"Overview of non-Hodgkin's lymphoma","volume":"22","author":"Rogers","year":"2006","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.bbmt.2010.03.014_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11764-007-0004-3","article-title":"Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivors","volume":"1","author":"Arora","year":"2007","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.bbmt.2010.03.014_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.bmt.1705868","article-title":"Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma","volume":"40","author":"Gisselbrecht","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.014_bib19","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/10428190701435275","article-title":"Hematopoietic stem cell transplantation in peripheral T-cell lymphomas","volume":"48","author":"Paolo","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2010.03.014_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/10428190600923140","article-title":"Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma","volume":"47","author":"Santos","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2010.03.014_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000088416","article-title":"Autologous hematopoietic stem cell transplantation in non-Hodgkin's lymphomas","volume":"114","author":"Zinzani","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.moh.0000138682.13354.da","article-title":"Mantle cell lymphoma","volume":"11","author":"Bertoni","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2005.10.001","article-title":"Treatment of mantle cell lymphoma: current approach and future directions","volume":"58","author":"Brody","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl 5","key":"10.1016\/j.bbmt.2010.03.014_bib24","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.3816\/CLM.2007.s.021","article-title":"Expanding therapeutic options in mantle cell lymphoma","volume":"7","author":"Goy","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.bbmt.2010.03.014_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MOH.0b013e328302c9c5","article-title":"Mantle cell lymphoma: advances in biology and therapy","volume":"15","author":"Smith","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib26","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/S1525-0016(16)38759-7","article-title":"Unexpected toxicity of cyclophosphamide followed by adoptively transferred CD19-targeted T cells in a patient with bulky CLL","volume":"17","author":"Brentjens","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.bbmt.2010.03.014_bib27","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1182\/blood-2005-08-3503","article-title":"Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK\u2013modified donor T cells after allogeneic hematopoietic cell transplantation","volume":"107","author":"Berger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.03.014_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/JVI.75.2.799-808.2001","article-title":"Nonmyeloablative immunosuppressive regimen prolongs in vivo persistence of gene-modified autologous T cells in a nonhuman primate model","volume":"75","author":"Berger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib29","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/0008-5472.CAN-07-5600","article-title":"Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system","volume":"68","author":"Singh","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.03.014_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","article-title":"Adoptive immunotherapy for cancer: building on success","volume":"6","author":"Gattinoni","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.03.014_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1062589","article-title":"Arrested differentiation, the self-renewing memory lymphocyte, and vaccination","volume":"293","author":"Fearon","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.03.014_bib33","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"Pule","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2010.03.014_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8 T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:36:30Z","timestamp":1761057390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1083879110001199"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.03.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20\/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}